Evaluation Based on Completeness of Vision and Ability to Execute
Dell SecureWorks, an industry leader in information security services, today announced it has been positioned by Gartner Inc. in the “Leaders” quadrant of the “Magic Quadrant for Global MSSPs” (March 2014).1
According to the Gartner report, “each of the services providers in the ‘Leaders’ quadrant has significant mind share among enterprises looking to buy an MSS as a discrete offering. These providers typically receive very positive reports on service and performance from Gartner clients. MSSPs in the Leaders quadrant are typically appropriate options for enterprises requiring frequent interaction with the MSSP for analyst expertise and advice, for portal-based correlation and workflow support, and for flexible reporting options.”
The report also said, “The 2013-2014 Magic Quadrant for Global MSSPs’ multiregional delivery requirements, and the MSSPs included in the evaluation meet the minimum thresholds for MSS business in two or more regions. MSSPs with multiregional business typically have a sufficient understanding of region-specific customer requirements, as well as sufficient service delivery capabilities that can scale to support global service delivery. Customers with a mix of global delivery requirements and local regulatory requirements related to, for example, data privacy, may require customised services.”
“We believe our positioning in the ‘Leaders’ quadrant of the ‘Magic Quadrant for Global MSSPs’ is a further testament to Dell SecureWorks’ commitment to protect the information assets of our clients, no matter where they are located around the globe,” said Mike Cote, Vice President and General Manager of Dell SecureWorks. “Dell SecureWorks has a worldwide presence in more than 70 countries. In the past year, we expanded service offerings in Japan, Australia and New Zealand, while adding to our existing security expertise in Europe and India.”
“Because the cyber-attack landscape can change quickly, we are continually expanding our portfolio of security services to help our clients defend against current and emerging cyber threats,” continued Cote. “This month, we launched our Managed Security Awareness Programs and Managed Phishing Services to help organisations combat the flood of information security threats by teaching their employees information security best practices. These are just the first of several new information security services we will be providing to our clients in 2014.”
The Gartner report also concluded, “As enterprises gain experience with technologies to analyse networks, payloads and endpoints for advanced attacks, they will look for opportunities to focus internal resources on prevention and response activities, and to augment those activities with external expertise to monitor and manage the technologies.”
With thousands of clients worldwide, Dell SecureWorks processes more than 70 billion cyber events daily, giving the security provider an unparalleled view into the attack landscape. This intelligence, combined with the expertise of its renowned Counter Threat Unit (CTU) research team and the advanced technology of its Counter Threat Platform, enables Dell SecureWorks to correlate, analyse and condense billions of cyber events into actionable, meaningful intelligence.
Dell SecureWorks offers a wide-range of security solutions, including its award-winning Managed Security Services, Threat Intelligence,Security & Risk Consulting and Incident Response and Digital Forensics services.
About Dell SecureWorks
Dell Inc. listens to customers and delivers innovative technology and services that give them the power to do more. Recognised as an industry leader by top analysts, Dell SecureWorks provides world-class information security services to help organisations of all sizes protect their IT assets comply with regulations and reduce security costs. For more information, visit www.secureworks.com.
Dell is a trademark of Dell Inc.
Dell disclaims any proprietary interest in the marks and names of others.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner’s research organisation and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner “Magic Quadrant for Global MSSPs” by Kelly M. Kavanagh, 26 February 2014.
Oil slips after U.S. crude stocks rise amid deep freeze hit to refiners
By Sonali Paul
MELBOURNE (Reuters) – Oil prices fell in early trade on Wednesday after industry data showed U.S. crude inventories unexpectedly rose last week as a deep freeze in the southern states curbed demand from refineries that were forced to shut.
Crude stockpiles rose by 1 million barrels in the week to Feb. 19, the American Petroleum Institute (API) reported on Tuesday, against estimates for a draw of 5.2 million barrels in a Reuters poll.
API data showed refinery crude runs fell by 2.2 million bpd.
U.S. West Texas Intermediate (WTI) crude futures were down 55 cents or 0.9% at $61.12 a barrel at 0136 GMT, after slipping 3 cents on Tuesday.
Brent crude futures fell 38 cents, or 0.6%, to $64.99 a barrel, erasing Tuesday’s 13 cents gain.
Investors will be awaiting confirmation from the U.S. Energy Information Administration later on Wednesday that crude inventories rose last week, despite the hit to shale oil production amid the unprecedented icy spell in the U.S. south.
“The key question is how quickly does U.S. oil supply recover. It looks like supply will recover faster than refineries, and supply is going to outpace demand in the next few weeks. That will give negative weight to the market,” Commonwealth Bank analyst Vivek Dhar said.
The price retreat is being seen as a pause following a rally of more than 26% to 13-month highs in both Brent and WTI since the start of the year.
Prices have jumped due to the U.S. supply disruption and supply discipline by the Organization of the Petroleum Exporting Countries and allies, together called OPEC+, led by an extra 1 million bpd cut by Saudi Arabia.
At the same time stimulus spending to boost growth, investors rotating into commodities, and hopes that the rollout of vaccinations could lead to an easing of pandemic restrictions are all buoying oil prices.
(Reporting by Sonali Paul; Editing by Edwina Gibbs)
Oil settles mixed amid post-storm uncertainty
By Laura Sanicola
NEW YORK (Reuters) – Oil prices settled near year-long highs on Tuesday on signs that global coronavirus restrictions were being eased, although concerns about the pace of a U.S. economic recovery and the return of Texas oil production kept gains in check.
U.S. crude settled down 3 cents to $61.67 a barrel, still close to its highest levels since January 2020. Brent crude <LCOc1> settled up 13 cents, or 0.2%, to $65.37 a barrel.
Both contracts rose more than $1 earlier before retreating.
Shale oil producers and refiners in the southern United States are slowly resuming production after 2 million barrels per day (bpd) of crude output and nearly 20% of U.S. refining capacity shut down because of last week’s winter storm.
Traffic at the Houston ship channel was slowly returning to normal. Production, however, was not expected to fully restart soon and some shale producers forecast lower oil output in the first quarter.
Some oil production may never come back, commodities merchant Trafigura said on Tuesday.
After the cold snap, U.S. crude oil stockpiles were also seen falling for a fifth straight week, while the inventories of refined products also declined last week, an extended Reuters poll showed.
“It appears that last week’s severe cold spell and related Texas power outage could be affecting the weekly EIA data into the middle of next month,” said Jim Ritterbusch, president of Ritterbusch and Associates in Galena, Illinois.
There were also concerns over the U.S. economic recovery, which the chair of the Federal Reserve, Jerome Powell, said remained “uneven and far from complete.”
He said it would be “some time” before the central bank considered changing policies it had adopted to help the country back to full employment.
Commerzbank analyst Eugen Weinberg said the recent oil price rise was buoyed by upbeat price forecasts from U.S. brokers.
Goldman Sachs expects Brent prices to reach $70 per barrel in the second quarter from the $60 it predicted previously, and $75 in the third quarter from $65 forecast earlier.
Morgan Stanley, which expects Brent to reach $70 in the third quarter, said new COVID-19 cases were falling while “mobility statistics are bottoming out and are starting to improve”.
Bank of America said Brent prices could temporarily spike to $70 in the second quarter.
(Reporting by Laura Sanicola in New York; Additional reporting by Bozorgmehr Sharafedin in London and Jessica Jaganathan in Singapore; Editing by Matthew Lewis and Mark Heinrich)
Exclusive: AstraZeneca to miss second-quarter EU vaccine supply target by half – EU official
By Francesco Guarascio
BRUSSELS (Reuters) – AstraZeneca expects to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter, an EU official told Reuters on Tuesday.
The expected shortfall, which has not previously been reported, comes after a big reduction in supplies in the first quarter and could hit the EU’s ability to meet its target of vaccinating 70% of adults by the summer.
The EU official, who is directly involved in talks with the Anglo-Swedish drugmaker, said the company had told the bloc during internal meetings that it “would deliver less than 90 million doses in the second quarter”.
AstraZeneca’s contract with the EU, which was leaked last week, showed the company had committed to delivering 180 million doses to the 27-nation bloc in the second quarter.
“Because we are working incredibly hard to increase the productivity of our EU supply chain, and doing everything possible to make use of our global supply chain, we are hopeful that we will be able to bring our deliveries closer in line with the advance purchase agreement,” a spokesman for AstraZeneca said, declining to comment on specific figures.
A spokesman for the European Commission, which coordinates talks with vaccine manufacturers, said it could not comment on the discussions as they were confidential.
He said the EU should have more than enough shots to hit its vaccination targets if the expected and agreed deliveries from other suppliers are met, regardless of the situation with AstraZeneca.
The EU official, who spoke to Reuters on condition of anonymity, confirmed that AstraZeneca planned to deliver about 40 million doses in the first quarter, again less than half the 90 million shots it was supposed to supply.
AstraZeneca warned the EU in January that it would fall short of its first-quarter commitments due to production issues. It was also due to deliver 30 million doses in the last quarter of 2020 but did not supply any shots last year as its vaccine had yet to be approved by the EU.
All told, AstraZeneca’s total supply to the EU could be about 130 million doses by the end of June, well below the 300 million it committed to deliver to the bloc by then.
The EU has also faced delays in deliveries of the vaccine developed by Pfizer and BioNTech as well as Moderna’s shot. So far they are the only vaccines approved for use by the EU’s drug regulator.
AstraZeneca’s vaccine was authorised in late January and some EU member states such as Hungary are also using COVID-19 shots developed in China and Russia.
OUTPUT BOOST DOWN THE LINE?
While drugmakers developed COVID-19 vaccines at breakneck speed, many have struggled with manufacturing delays due to complex production processes, limited facilities and bottlenecks in the supply of vaccine ingredients.
According to a German health ministry document dated Feb. 22, AstraZeneca is forecast to make up all of the shortfalls in deliveries by the end of September.
The document seen by Reuters shows Germany expects to receive 34 million doses in the third quarter, taking its total to 56 million shots, which is in line with its full share of the 300 million doses AstraZeneca is due to supply to the EU.
The German health ministry was not immediately available for a comment.
If AstraZeneca does ramp up its output in the third quarter, that could help the EU meet its vaccination target, though the EU official said the bloc’s negotiators were wary because the company had not clarified where the extra doses would come from.”Closing the gap in supplies in the third quarter might be unrealistic,” the official said, adding that figures on deliveries had been changed by the company many times.
The EU contracts stipulates that AstraZeneca will commit to its “best reasonable efforts” to deliver by a set timetable.
“We are continuously revising our delivery schedule and informing the European Commission on a weekly basis of our plans to bring more vaccines to Europe,” the AstraZeneca spokesman said.
Under the EU contract leaked last week, AstraZeneca committed to producing vaccines for the bloc at two plants in the United Kingdom, one in Belgium and one in the Netherlands.
However, the company is not currently exporting vaccines made in the United Kingdom, in line with its separate contract with the British government, EU officials said.
AstraZeneca also has vaccine plants in other sites around the world and it has told the EU it could provide more doses from its global supply chain, including from India and the United States, an EU official told Reuters last week.
Earlier this month, AstraZeneca said it expected to make more than 200 million doses per month globally by April, double February’s level, as it works to expand global capacity and productivity.
(Reporting by Francesco Guarascio @fraguarascio; Additional reporting by Andreas Rinke and Sabine Siebold; Editing by David Clarke)
Promise of cheap money keeps stocks buoyant
By Tom Westbrook and Echo Wang SINGAPORE/MIAMI (Reuters) – Bond markets steadied, the U.S. dollar fell and stocks edged ahead...
Bonding with equities
By Rupert Thompson, Chief Investment Officer at Kingswood Global equities slipped back last week, retreating 1.5% in sterling terms, and...
Dollar falls as risk appetite increases, kiwi ruffled by RBNZ
By Stanley White TOKYO (Reuters) – The dollar slipped to a three-year low against the British pound and fell against...
Oil slips after U.S. crude stocks rise amid deep freeze hit to refiners
By Sonali Paul MELBOURNE (Reuters) – Oil prices fell in early trade on Wednesday after industry data showed U.S. crude...
British fund industry warns companies on ethnic diversity
By Simon Jessop LONDON (Reuters) – Britain’s investment industry trade body has warned companies they must show progress on boardroom...
GameStop CFO to step down after Reddit driven stock rally
By Jessica DiNapoli and Subrat Patnaik NEW YORK (Reuters) – GameStop Chief Financial Officer Jim Bell will step down next...
Investors jolted by sinking Bitcoin, Tesla and other market favorites
By Julien Ponthus, Aaron Saldanha and April Joyner LONDON/NEW YORK (Reuters) – Bitcoin, shares of Tesla and a high-flying exchange...
A new wave of talent for financial services – how career switchers can accelerate digital performance
By Claudia Harris, CEO, Makers, a leading coding provider Covid-19 has done a lot to undermine economic growth. However it...
Exclusive: CDP consortium’s bid to value Atlantia unit at 9 billion euros – sources
By Francesca Landini and Giuseppe Fonte MILAN (Reuters) – Cassa Depositi e Prestiti (CDP) on Tuesday gave the go-ahead to...
Stocks rebound on Powell policy remarks, oil gains
By Herbert Lash NEW YORK (Reuters) – A gauge of global equity markets rebounded in a late-session rally on Tuesday...